Lv2
110 积分 2024-12-17 加入
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
1个月前
已完结
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
1个月前
已完结
Therapeutic targeting of mismatch repair-deficient cancers
1个月前
已完结
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
3个月前
已完结
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
3个月前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
3个月前
已完结
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
3个月前
已完结
The Biomarkers Consortium: 20 years of advancing precision medicine
3个月前
已完结
Evolutionary Overview and Future Perspectives: ESR1 Mutations, Liquid Biopsy, and Artificial Intelligence for a New Era of Personalized Medicine in ER+ Breast Cancer
4个月前
已完结
Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes
8个月前
已完结
皖公网安备34019202002308
